Description Infant Bacterial Therapeutics
Infant Bacterial Therapeutics is a Swedish biopharmaceutical company focused on developing therapies for diseases affecting premature infants. Its lead program, IBP-9414, is being studied for the prevention of necrotizing enterocolitis and related conditions.